VCG. Tesla’s Shanghai Gigafactory stood out as a major growth engine in the American EV giant’s second-quarter earnings, released o ……
Shanghai Gigafactory posts 28.4% H1 delivery growth as China powers Tesla’s record Q2
VCG. Tesla’s Shanghai Gigafactory stood out as a major growth engine in the American EV giant’s second-quarter earnings, released o ……
Shanghai Gigafactory posts 28.4% H1 delivery growth as China powers Tesla’s record Q2
VCG. Tesla’s Shanghai Gigafactory stood out as a major growth engine in the American EV giant’s second-quarter earnings, released o ……
Singapore Businesses Brace for Impacts of Upcoming RTS Link
Businesses in northern Singapore are preparing for the imminent opening of the RTS Link, which is set to reshape the…
Singapore Businesses Brace for Impacts of Upcoming RTS Link comes from ChinaRetailNews.com. ChinaRetailNews.com: ChinaRetailNews.com……
Nike Initiates Bold Strategy to Revive Sales in China by Restricting Online Sellers
Nike is implementing a bold strategy in China aimed at reviving its sales and regaining control over pricing dynamics. Following…
Nike Initiates Bold Strategy to Revive Sales in China by Restricting Online Sellers comes from ChinaRetailNews.com. Chin……
Chinese Investment Bill Threatens Mercedes and U.S. Automakers
In a pivotal legislative move, the Senate Commerce Committee is on the verge of implementing restrictive measures to block Chinese……
US Startups Urge Government to Reconsider Ban on Chinese AI Models
A growing conflict revolving around Chinese artificial intelligence has extended its reach to Silicon Valley. About 200 startups have jointly……
Chinese Economy Awash with Thriving Private Funds Influx
China’s private securities investment funds have surged to over 8 trillion yuan (US$1.2 trillion) marking a significant milestone in the……
China’s Involvement Facing Scrutiny: FCC Ruling Prohibits Sale of Devices from High-Risk Chinese Firms
The Federal Communications Commission (FCC) issued a groundbreaking ruling to prevent the sale of electronic devices incorporating parts from Chinese……
AI shortens drug discovery to around 1 year in China, Insilico CEO says
By Laurie Chen SHANGHAI, July 23 (Reuters) – Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said, ……
-
-
Recent Updates
- China’s Fibocom Pitches Cat M Module as a Buffer against Memory Supply Risk
- Instituto Sul Global and Shanghai Academy sign agreement to strengthen Brazil-China academic cooperation
- Chinese Import Charges Push Irish Shoppers to Rethink Online Buying
- Chinese Travelers Get Easier Pix Payments in Brazil through Weixin Pay
- AlphaPai Takes China AI Investment Research Platform to Global Markets
- China AI Stocks Slide as Nvidia Upheaval Revives US Chip Fears
- China Chip Links Deepen Scrutiny of Alice Huang and Nvidia Figure Jensen Huang
- Nvidia Scandal Deepens as China Links Raise Questions About Alice Huang
- Nvidia China Scandal Pulls Trump Administration Into Congressional Crossfire
- Wuhan to Shanghai on China’s fastest bullet train
Blogroll